← Browse by Condition
Medical Condition

early onset parkinson s disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06608355 Phase 1
Recruiting

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Enrollment
6 pts
Location
China
Sponsor
iRegene Therapeutics Co., Ltd.
View Trial →